Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes inflammation and damage to joints and other tissues. Antirheumatic drugs, including disease-modifying antirheumatic drugs (DMARDs), biologic agents, and non-steroidal anti-inflammatory drugs (NSAIDs), play a crucial role in the treatment and management of RA. This review examines the mechanisms of action, clinical efficacy, and adverse effects of these drugs. We also explore emerging therapies and future directions for RA management, highlighting the importance of individualized treatment strategies to improve patient outcomes while minimizing potential risks.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Scientific Research in Science and Technology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
